Public-registry trials using H021 Enteric-coated Tablets Low-dose Group that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease | Jiangsu Carephar Pharmaceutical Co., Ltd. | Crohn's Disease | PHASE2 | 24 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →